Correlation Between Cytosorbents Crp and Elite Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytosorbents Crp and Elite Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytosorbents Crp and Elite Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytosorbents Crp and Elite Pharma, you can compare the effects of market volatilities on Cytosorbents Crp and Elite Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytosorbents Crp with a short position of Elite Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytosorbents Crp and Elite Pharma.

Diversification Opportunities for Cytosorbents Crp and Elite Pharma

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cytosorbents and Elite is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Cytosorbents Crp and Elite Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elite Pharma and Cytosorbents Crp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytosorbents Crp are associated (or correlated) with Elite Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elite Pharma has no effect on the direction of Cytosorbents Crp i.e., Cytosorbents Crp and Elite Pharma go up and down completely randomly.

Pair Corralation between Cytosorbents Crp and Elite Pharma

If you would invest  138.00  in Cytosorbents Crp on September 28, 2024 and sell it today you would lose (49.00) from holding Cytosorbents Crp or give up 35.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy0.37%
ValuesDaily Returns

Cytosorbents Crp  vs.  Elite Pharma

 Performance 
       Timeline  
Cytosorbents Crp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cytosorbents Crp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Elite Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elite Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Elite Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Cytosorbents Crp and Elite Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytosorbents Crp and Elite Pharma

The main advantage of trading using opposite Cytosorbents Crp and Elite Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytosorbents Crp position performs unexpectedly, Elite Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elite Pharma will offset losses from the drop in Elite Pharma's long position.
The idea behind Cytosorbents Crp and Elite Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities